Metronidazole Extended-Release Formulation in the Management of Multidrug-Resistant Infections: Efficacy, Mechanisms, and Therapeutic Synergy with Current Treatment Options

Authors

  • Subarnarekha Maitra Faculty of Pharmacy, Lincoln University College, Selangor, Malaysia Author
  • Sreemoy Kanti Das Faculty of Pharmacy, Lincoln University College, Selangor, Malaysia Author
  • Dibya Sinha Assistant Professor, Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata- Group of Institutions. 60, B.L. Saha Road, Kolkata, 700053, India. Author
  • Tathagata Roy Assistant Professor, Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata- Group of Institutions. 60, B.L. Saha Road, Kolkata, 700053, India. Author
  • Sayani Chaki Roy Assistant Professor, Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata- Group of Institutions. 60, B.L. Saha Road, Kolkata, 700053, India. Author
  • Snehajyoti Ghosh Assistant Professor, Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata- Group of Institutions. 60, B.L. Saha Road, Kolkata, 700053, India. Author
  • Subhankar Das Assistant Professor, Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata- Group of Institutions. 60, B.L. Saha Road, Kolkata, 700053, India. Author
  • Maitreyee Mukherjee Assistant Professor, Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata- Group of Institutions. 60, B.L. Saha Road, Kolkata, 700053, India. Author

DOI:

https://doi.org/10.48047/fq0jjn14

Keywords:

Metronidazole, Metronidazole extended-release formulation, Multidrug-Resistant Infections, Alternative therapy, Multidrug Strategy.

Abstract

Multidrug-resistant (MDR) infections are becoming more prevalent, which presents serious problems for global healthcare
and calls for creative approaches to treatment as well as a reassessment of current medications. Because of its strong
anaerobic and protozoal action, Metronidazole extended-release formulation has demonstrated promise in treating various
MDR illnesses. The function of Metronidazole extended-release formulation in treating MDR infections is examined in
various studies, with a focus on anaerobic bacteria that are frequently present in soft-tissue, pelvic, and intra-abdominal
infections. The prolonged-release formulation has advantages, such as sustained therapeutic levels and a decreased dosing
frequency, which may improve patient adherence and clinical outcomes, even though it is effective in treating diseases like
bacterial vaginosis, Clostridium difficile infections, etc. This study addresses existing limitations and offers insights into
improving treatment for MDR infections by contrasting Metronidazole extended-release formulation with alternative and
complementary medicines, including glycopeptides, carbapenems, and combination regimens. Although Metronidazole
extended-release formulation is still a useful treatment option for MDR infections, its effectiveness is best complemented
by a multidrug strategy that is customized to the complexity and resistance profile of the illness.

Downloads

Download data is not yet available.

Downloads

Published

2025-02-20

How to Cite

Metronidazole Extended-Release Formulation in the Management of Multidrug-Resistant Infections: Efficacy, Mechanisms, and Therapeutic Synergy with Current Treatment Options (S. . Maitra, S. . Kanti Das, D. . Sinha, T. . Roy, S. . Chaki Roy, S. . Ghosh, S. . Das, & M. . Mukherjee , Trans.). (2025). Cuestiones De Fisioterapia, 54(4), 6285-6297. https://doi.org/10.48047/fq0jjn14